Nucleic Acid Nanotechnology-Empowered CRISPR-Cas12a Systems for Biosensing and Bioimaging Applications

Area of Science:

• Molecular Biology
• Biotechnology
• Nanotechnology

Background:

• Highly sensitive bioanalytical platforms are essential for disease diagnostics and biomedical research.
• CRISPR-Cas systems, particularly CRISPR-Cas12a, are revolutionary tools for genome editing and molecular diagnostics.
• CRISPR-Cas12a's target specificity and ease of design make it valuable for biosensing and bioimaging.

Purpose of the Study:

• To review the fundamentals of CRISPR-Cas12a and nucleic acid nanotechnology.
• To systematically summarize the advantages of integrating nucleic acid nanotechnology with CRISPR-Cas12a platforms.
• To highlight recent advances and discuss future perspectives of these systems in disease diagnostics.

Main Methods:

• Review of CRISPR-Cas12a system fundamentals.
• Exploration of nucleic acid nanotechnology toolboxes (amplification, functional nucleic acids).
• Systematic summary and analysis of integrated CRISPR-Cas12a and nucleic acid nanotechnology platforms.

Main Results:

• Integration significantly enhances detection sensitivity and specificity of CRISPR-Cas12a systems.
• Enables the analysis of low-abundance analytes crucial for early disease detection.
• Demonstrates broad applicability in advanced biosensing and bioimaging techniques.

Conclusions:

• Nucleic acid nanotechnology-empowered CRISPR-Cas12a platforms represent a significant advancement in biosensing.
• These integrated systems hold immense potential for improving disease diagnostics and biomedical research.
• Addressing current challenges will further unlock the future potential of these nucleic acid-assisted CRISPR-Cas12a systems.